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Abstract
Background: We evaluated the associations among the well-known atrial fibrillation (AF) 
predictors including P-wave dispersion (PWD), intra- and inter-atrial electromechanical dyssyn-
chrony (EMD), left atrial (LA) phasic functions, and plasma N-terminal prohormone of B-type 
natriuretic peptide (NT-proBNP) levels, in patients with hypertrophic cardiomyopathy (HCM).
Methods: Seventy patients with HCM and age and sex matched 70 subjects were enrolled. 
PWD, LA total emptying fraction (LATEFr), active emptying fraction (LAAEFr), passive 
emptying fraction (LAPEFr), expansion index (LAEI) intra- and inter-atrial EMD were cal-
culated. Levels of NT-proBNP of all subjects were determined.
Results: Higher PWD (p = 0.006), significantly decreased LAEI (p < 0.001), LATEFr, and 
LAPEFr (both p values < 0.001) values and significantly increased inter-atrial (p < 0.001), 
LA (p = 0.001), and right atrial dyssynchrony (p < 0.001) were observed in the HCM group 
compared to controls. PWD was negatively correlated with LAEI (r = –0.236, p = 0.005) and 
LATEFr (r = –0.242, p = 0.04), however not with LAPEFr (p = 0.7), or LAAEFr (p = 0.3). 
Except for the LA lateral wall PA’ (r = 0.283, p = 0.02), PWD was not correlated with any 
atrial EMD parameter. Inter-atrial dyssynchrony was related to LAEI (r = –0.272, p = 0.001), 
LATEFr (r = –0.256, p = 0.03), and LAPEFr (r = –0.332, p = 0.006), but not, however, to 
LAAEFr (p = 0.4). The plasma NT-proBNP levels of patients were not correlated with either 
PWD (p = 0.927) or inter-atrial dyssynchrony (p = 0.102).
Conclusions: PWD and inter-atrial dysynchrony seem to independently promote AF, although 
both are associated with LA reservoir function in HCM populations. The NT-proBNP level is 
not associated with these two AF predictors in patients with HCM. NT-proBNP seems to be  
a poor marker of atrial electrical remodeling in HCM patients. (Cardiol J 2015; 22, 1: 94–100)
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Introduction
Alterations in left atrial (LA) functions [1], atrial 
fibrosis [2], and even LA appendage dysfunction [3], 
have been reported in patients with hypertrophic 
cardiomyopathy (HCM). Changes in atria may lead 
to electrical remodeling and affect the conduction 
properties of the atria, as is true in other cardiac 
pathologies [4]. Prolongation of atrial conduction can 
be assessed noninvasively by surface electrocardio-
graphy (ECG) measuring P wave duration (Pdur) [5] 
and and by tissue Doppler imaging (TDI) assessing 
atrial electromechanical dyssynchrony (EMD) [6]. 
These parameters and LA phasic functions have 
been used widely to predict development of atrial 
fibrillation (AF) episodes in patients with various 
heart diseases [5–7]. Patients with HCM are more 
prone to development of AF, which is suggested to 
be a strong determinant of HCM-related morbidity 
and is the most common disease variable associated 
with progressive heart failure [8].
The levels of the amino-terminal portion 
of pro-BNP (N-terminal prohormone of B-type 
natriuretic peptide [NT-proBNP]) are elevated in 
patients with HCM [1]. Studies focusing on atrial 
functions showed that NT-proBNP levels also re-
flected LA dysfunction in patients with structural 
heart disease [9]. Increased levels of NT-proBNP 
are also known to be related to the AF burden [10].
In the current study, we investigated the 
associations among well-known AF predictors, 
including P wave dispersion (PWD), intra- and 
inter-atrial dyssynchrony, LA phasic functions, and 
plasma NT-proBNP levels, in patients with HCM. 
Methods
Patients with established diagnoses of HCM 
[11] were enrolled. All patients were in sinus 
rhythm (SR) and underwent 24-h Holter ECG 
monitoring before enrollment. Patients with any 
of the following were excluded: (1) mitral annu-
lar calcification; (2) bundle branch block; (3) any 
wall-motion abnormality or left ventricular (LV) 
systolic dysfunction; (4) any pulmonary or meta-
bolic disorder; (5) prior pacemaker implantation; 
(6) moderate to severe valvular disease; (7) prior 
intervention to alleviate LV outflow obstruction; 
(8) presence of AF attacks on 24-h Holter ECG 
monitoring; (9) and treatment with anti-arrhythmic 
drugs other than beta-blockers or verapamil; 
(10) history of paroxysmal AF attacks. The study 
population consisted of 70 patients HCM with no 
complaint of palpitation who were in SR at the time 
of recruitment. If a patient took any medication, 
this was stopped ≥ 48 h before enrollment, when 
possible. The findings in patients were compared 
with those of a control group of 70 subjects. The 
findings in patients were compared with those of 
a control group of 70 age- and sex-matched healthy 
volunteered subjects who admitted to our center 
for medical examination who had normal physical 
examination findings.
All participants gave written informed consent 
to participate in the study, which was approved by 
the hospital Ethic Committee.
Echocardiographic analysis
Echocardiographic assessments were per-
formed using a Sonos 7500 ultrasound machine 
(Philips Medical Systems, Andover, MA) equi-
pped with a 2.5-MHz transducer, and recorded 
on VHS videotape. One-lead ECG was recorded 
continuously during all examinations. Measure-
ments were performed using the criteria of the 
American Society of Echocardiography [12]. The 
LA volumes (LAVs) were calculated from the 
4- and 2-chamber views, using Simpson’s rule. The 
following LAVs were measured: maximal volume 
(Vmax) during LV end-systole immediately before 
mitral valve opening; minimal volume (Vmin) just 
before mitral valve closure; and LAV before atrial 
contraction (VpreA) at the onset of the P wave of 
the simultaneously recorded ECG. Left atrial to-
tal emptying fraction (LATEFr) was calculated as 
[(Vmax – Vmin)/Vmax × 100%]; left atrial active 
emptying fraction (LAAEFr) as [(VpreA – Vmin)/ 
/VpreA × 100%]; left atrial passive emptying 
fraction (LAPEFr) as [(Vmax – Vpre A)/Vmax  × 
× 100%]; and left atrial expansion index (LAEI) as 
[(Vmax – Vmin)/Vmin × 100%] [13, 14].
The pulsed Doppler sample volume was placed 
at the lateral and septal sides of the mitral annulus, 
and the right ventricular (RV) tricuspid annulus, to 
obtain tissue Doppler velocities. The time interval 
from the onset of the P wave on surface ECG to 
the peak of the late diastolic wave (the A’ wave), 
termed PA’, was obtained from the lateral mitral 
annulus (lateral PA’), the septal mitral annulus (the 
septal PA’), and the RV tricuspid annulus (the tricu-
spid PA’) (Fig. 1) [15]. The difference between the 
lateral PA’ and tricuspid PA’ (lateral PA’ − tricuspid 
PA’) was defined as the inter-atrial dyssynchrony, 
while the intra-atrial dyssynchrony was defined 
as the difference between the septal PA’ and the 
tricuspid PA’ (right atrial [RA] dyssynchrony) and 
the lateral PA’ and the septal PA’ (LA dyssynchrony) 
[16]. All echocardiographic measurements were 
calculated as averages of data from 3 beats.
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Electrocardiographic analysis
A 12-lead resting surface ECG was obtained 
from all subjects (lying supine) at a paper speed 
of 50 mm/s and a signal size of 20 mm/mV, during 
SR, using a computer-based ECG system. Paper 
printouts of the averaged data from all 12 ECG le-
ads were scanned using a high-resolution scanner 
(Samsung SCX-4200 Multifunction, 600 × 600 dpi, 
Samsung Electronics Co., Ltd., Tokyo, Japan), 
transferred into computer memory, and opened 
using a high-performance graphic program (Auto-
desk AutoCAD 2011, Autodesk, Inc., San Rafael, 
CA). The P wave was magnified 1,000-fold using 
Autodesk. The start- and end-points of the P wave 
were defined as the junction between the P-wave 
pattern and the isoelectric line. P-wave duration 
was manually measured from the commencement 
to the end of the P wave, using digital calipers, on 
a high-resolution computer screen. Leads with 
baseline noise > 10 µV and/or a peak-to-peak 
isoelectric line-P wave amplitude of < 15 µV were 
excluded from analysis [9]. Subjects with mea-
surable P waves in ≥ 10 ECG leads were included 
in the study. P wave dispersion was defined as 
the difference between the maximum (Pmax) and 
minimum (Pmin) P-wave durations [7].
Statistical analysis
All analyses were performed using SPSS for 
Windows, version 18.0 (SPSS Inc., Chicago, IL). Re-
sults are presented as means ± standard deviations 
for continuous data or as numbers with percentages 
for categorical data. NT-proBNP levels were logarit-
hmically transformed. After performing the norma-
lity test, continuous variables were analyzed using 
Student’s t-test or the Mann-Whitney U test, as 
appropriate. Categorical data and proportions were 
analyzed using the c2 test. Associations between 
variables were examined by calculating Pearson 
correlations or by using the Spearman correlation 
test, as appropriate. Two-sided p values < 0.05 were 
considered to indicate statistical significance. The 
reproducibility of measures of Pmax, PWD, and atrial 
electromechanical coupling intervals obtained by 
TDI, was assessed by calculation of coefficients of 
variation (CV), which were the standard deviations 
of differences between repeated measurements di-
vided by the average values of those measurements, 
and are expressed as percentages.
Results
Baseline characteristics of the subjects are 
presented in Table 1. There were no significant 
differences between groups in terms of age, gender, 
heart rate, blood pressure, or body surface area. 
Clinical features of the HCM group are summa-
rized in Table 2. Thirty-nine (55.7%) patients had 
obstructive-type HCM. Before the concurrent me-
dications were stopped, 52 of our patients (74.3%) 
were on beta-blocker therapy while 2 (2.9%) were 
on calcium-channel therapy. The electrocardio-
graphic and echocardiographic parameters of the 
two groups are compared in Table 3. The Pmax 
(p < 0.001), Pmin (p = 0.02), and PWD (p = 0.006) 
values were significantly higher in HCM patients 
compared to controls. All PA’ values were sig-
nificantly longer in HCM patients. Comparison of 
tissue Doppler findings between groups showed 
a significant increase in inter-atrial (p < 0.001), 
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Figure 1. Electromechanical coupling interval from initiation of the P wave on electrocardiography to the peak of the 
late diastolic tissue Doppler imaging signal (A’).
LA (p = 0.001), and RA dyssynchrony (p < 0.001), in 
the HCM group (Table 3). Assessment of LA phasic 
functions revealed a significantly decreased LAEI 
(p < 0.001), total LA, and passive emptying frac-
tion (both p values < 0.001), in HCM patients, but 
no difference with respect to LAAEFr (p = 0.26) 
between the two groups (Table 3). Correlation anal-
ysis of the PWD with other parameters revealed 
that PWD was positively correlated with Vmax 
(r = 0.342, p = 0.004), while negatively correlated 
with LAEI (r = –0.236, p = 0.005) and LATEFr 
(r = –0.242, p = 0.04). Except for the LA lateral 
wall PA’ (r = 0.283, p = 0.02), PWD was not cor-
related with any atrial EMD parameter. No as-
sociations were detected between PWD and the 
degree of LV hypertrophy (p = 0.86), LAPEFr 
(p = 0.7), or LAAEFr (p = 0.3). Inter-atrial dyssyn-
chrony was related to Vmax (r = 0.276, p = 0.02), 
LAEI (r = –0.272, p = 0.001), LATEFr (r = –0.256, 
p = 0.03), and LAPEFr (r = –0.332, p = 0.006), but 
not, however, to LAAEFr (p = 0.4) (Table 4). The 
median NT-proBNP level was 711.5 pg/mL in the 
HCM group and 24 pg/mL in the control group. The 
plasma NT-proBNP levels of patients were corre-
lated with RA dyssynchrony (r = 0.31, p = 0.01), 
but not with PWD (p = 0.927) or inter-atrial dys-
synchrony (p = 0.102). 
Intra- and inter-observer CVs were 3.8% and 
4.9% for Pmax and 3.9% and 4.7% for PWD, re-
spectively. The CVs for intra- and inter-observer 
variability were 6.1% and 5.3% for lateral PA’; 
6.8% and 7.2% for septal PA’, and 5.5% and 5.7% 
for tricuspid PA’, respectively.
Discussion
We found that in patients with HCM, the LA 
total emptying fraction, the LA expansion index, 
and LA phasic volumes were commonly associa-
ted with PWD and inter-atrial dyssynchrony. No 
correlations were evident between PWD and LA 
electromechanical coupling intervals, except for 
the lateral PA’. No associations were detected 
between plasma NT-proBNP levels, and PWD and 
inter-atrial dyssynchrony, in patients with HCM. 
Interaction between PWD  
and atrial dyssynchrony
P-wave dispersion [5] on surface ECG and 
atrial EMD [6] have been reported as risk factors 
for development of AF in various heart diseases. 
However, only a few studies have evaluated the 
relationship between PWD and atrial dyssynchro-
ny. A positive correlation between inter-atrial 
electromechanical delay and PWD was shown 
in patients with mitral stenosis [17]. A strong 
correlation between the signal-averaged P-wave 
duration and total atrial activation time (defined as 
the time interval from the beginning of the P-wave 
on the ECG until the peak of the tissue A’-wave 
in the lateral LA wall) was found by Merckx et al. 
[18] in subjects during SR. A recent study focusing 
on the relationship between Pdur and atrial EMD 
in patients with sinus node disease, who were 
in different atrial pacing modalities, found that, 
upon univariate analysis, all parameters, except 
for RA dyssynchrony, correlated positively with 
the Pdur while, upon multivariate analysis, Pdur 
was associated only with the electromechanical 
delay in the lateral LA wall [19]. The lateral LA 
Table 1. Baseline characteristics of the study population.
HCM group (n = 70) Control group (n = 70) P
Age [years] 50.54 ± 12.86 49.26 ± 11.6 0.536
Females/males 25/45 24/46 0.86
Body surface area [m2] 1.87 ± 0.22 1.92 ± 0.19 0.089
Systolic blood pressure [mm Hg] 122.41 ± 15.58 125.8 ± 16.02 0.207
Diastolic blood pressure [mm Hg] 72.1 ± 11.19 71.34 ± 12.16 0.702
Continuous data are expressed as means ± standard deviation; HCM — hypertrophic cardiomyopathy
Table 2. Clinical features of the hypertrophic car-
diomyopathy group.
Type of hypertrophy:
Asymmetric septal hypertrophy 62 (88.6%)
Concentric 4 (5.7%)
Midventricular 3 (4.3%)
Apical 1 (1.4%)
Mitral regurgitation:
No 10 (14.3%)
Mild 27 (38.6%)
Moderate 33 (47.1%)
Obstruction 39 (55.7%)
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Table 4. Correlation of P-wave dispersion and inter-atrial dyssynchrony with other parameters.
Variables P wave dispersion
 r (p value)
Inter-atrial dyssynchrony
r (p value)
Log NT-proBNP –0.012 (0.927) 0.203 (0.102)
LV mass index –0.078 (0.86) 0.232 (0.053)
LA maximum 0.26 (0.024) 0.286 (0.013)
LAV preA 0.328 (0.006) 0.373 (0.002)
LAV minimum 0.301 (0,01) 0.337 (0.004)
LAV maximum   0.342 (0.004) 0.276 (0.02)
LA expansion index –0.236 (0.005) –0.272 (0.001)
LA total emptying fraction –0.242 (0.04)  –0.256 (0.03)
LA passive emptying fraction –0.046 (0.7) –0.332 (0.006)
LA active emptying fraction –0.137 (0.3)  –0.095 (0.4)
Lateral PA’ 0.283 (0.02) 0.412 (< 0.001) 
Septal PA’ 0.218 (0.07) 0.07 (0.5)
Tricuspid PA’ 0.144 (0.2) –0.454 (<0.001)
LA dyssyncrony 0.165 (0.2) 0.441 (< 0.001)
RA dyssyncrony 0.02 (0.9) 0.556 (< 0.001)
Inter-atrial dyssyncrony 0.107 (0.38) –
P wave dispersion – 0.107 (0.38)
LA — left atrium; LV — left ventricul; LAV — left atrial volume; LAVpreA — left atrial volume before atrial contraction; PA’ — time interval 
from the onset of the P wave on surface ECG to the peak of the late diastolic wave; RA — right atrium
Table 3. Comparison of baseline electrocardiographic and echocardiographic findings between groups.
HCM group Control group P
Echocardiographic findings
IVS thickness [cm] 2.02 ± 0.45 0.95 ± 0.13 < 0.001
Posterior wall thickness [cm] 1.07 ± 0.27 0.81 ± 0.09 < 0.001
LV mass index [g/m²] 143.3 ± 47.03 67.56 ± 12.87 < 0.001
Ejection fraction [%] 66.69 ± 6.76 65.30 ± 5.45 0.181
LAV preA [mL] 64.8 ± 27.2 31.8 ± 11.3 < 0.001
LAV minimum [mL] 39.5 ± 22.2 18.2 ± 7.4 < 0.001
LAV maximum [mL] 82.23 ± 33.04 47.08 ± 14.23 < 0.001
Electrocardiographic findings
Heat rate [bpm] 68.27 ± 11.26 69.56 ± 9.25 0.46
P maximum [ms] 126.21 ± 14.1 116.57 ± 12.81 < 0.001
P minimum [ms] 85.57 ± 18.23 79.64 ± 10.19 0.02
P wave dispersion [ms] 43.5 ± 16.29 37.07 ± 10.61 0.006
Electromechanical coupling interval (PA’) [ms]
Lateral PA’ 150.07 ± 23.59 124.21 ± 11.59 < 0.001
Septal PA’ 132.64 ± 23.45 110.14 ± 12.54 < 0.001
Tricuspid PA’ 109.93 ± 23.81 96.57 ± 14.36 < 0.001
Inter-atrial asynchrony 42.29 ± 17.87 27.64 ± 12.27 < 0.001
LA dyssynchrony 20.43 ± 14.13 13.93 ± 8.42 0.001
RA dyssynchrony 25.43 ± 17.33 13.57 ± 8.43 < 0.001
LA phasic functions [%]
LA expansion index 129.7 ± 57.2 174.5 ± 60.9 < 0.001
LA total emptying fraction 54.47 ± 11.46 62.01 ± 8.25 < 0.001
LA passive emptying fraction 21.45 ± 10.07 33.05 ± 10.43 < 0.001
LA active emptying fraction 40.78 ± 14.41 43.25 ± 10.55 0.26
Continuous data are expressed as means ± standard deviation; IVS — interventricular septum; LA — left atrium; LV — left ventricular; LAV — 
left atrial volume; LAV preA — left atrial volume before atrial contraction; PA’ — time interval from the onset of the P wave on surface ECG to 
the peak of the late diastolic wave; RA — right atrium
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wall PA’ estimates total atrial activation time 
[20] and has been shown to predict maintenan-
ce of SR after cardioversion in patients with 
persistant AF [21]. In the present study, PWD 
was related only to the lateral LA wall PA’, thus 
not to intra- and inter-atrial dyssynchrony, in 
patients with HCM. This suggests that inter-
-atrial dyssynchrony is explained not only by LA 
structural and electrical remodeling, but also by 
the time elapsing from electrical activation in 
the atrium to atrial myocardial contraction. The 
observed lack of correlation between PWD and 
inter-atrial dysynchrony may indicate that these 
2 parameters are relatively independent in terms 
of promoting AF in HCM populations. 
Relationships of PWD and atrial EMD  
to LA phasic volumes 
The LAV is known to be a predictor of AF in 
patients with HCM [22]. In our study, both PWD 
and inter-atrial dyssynchrony were correlated 
with all phasic LAVs. Our findings are similar to 
those of previous studies evaluating patients with 
mitral stenosis [17], and sinus node disease wit-
hout structural heart disease [19]. The positive 
correlation between phasic LAVs, and PWD and 
atrial dyssynchrony, may suggest that these two 
AF predictors are affected by LA structural re-
modeling. Chronic elevation of LV filling pressure 
in patients with HCM may cause secondary atrial 
myopathy [1], contributing to atrial dyssynchrony 
and prolongation of PWD.
Relationships of PWD and atrial EMD  
to LA phasic functions 
No relationship between LA phasic functions 
and PWD and atrial EMD has yet been shown. In 
the present study, we found negative correlations 
between LA reservoir functions (the LA expansion 
index and the LA total emptying fraction), and PWD 
and atrial dyssynchrony; however, the LA active 
emptying fraction was not associated with these 
2 parameters. Schneider et al. [23] investigated 
atrial deformation properties in an effort to predict 
maintenance of SR in patients undergoing cathe-
ter ablation for AF, and showed that LA reservoir 
function parameters, rather than LA contractile 
functions, were the best predictors of maintenance 
of SR in such patients. In another study, the pre-
sence of atrial dyssynchrony during the reservoir 
period, but not during the atrial contraction period, 
was associated with future development of AF in 
patients with congestive heart failure [24]. The 
LA active emptying fraction in the HCM popula-
tion has been shown to follow the Frank-Starling 
mechanism [1], so an increase in LA preload up to 
a certain point contributes to enhanced LA booster 
pump function, which might explain why this fun-
ction does not predict development of AF. On the 
other hand, LA reservoir function parameters are 
affected mostly by atrial compliance [25], and show 
advanced remodeling rather than LA enlargement. 
This may explain the value of this function in pre-
dicting AF [26].
Relationships of PWD and atrial EMD  
to NT-proBNP levels
A recent study showed a direct correlation 
between plasma NT-proBNP levels and the AF 
burden [10]. Elevation of plasma NT-proBNP 
levels, despite the absence of obvious structural 
heart disease, was evident in patients with chronic 
AF, and no relationship was found between plasma 
NT-proBNP levels and intra-atrial conduction time 
(measured as the filtered Pdur) after cardioversion, 
in a previous study [27]. Evaluation of patients 
with persistent AF found that the baseline plasma 
BNP level and the magnitude of the decrease the-
reof after successful cardioversion, predicted AF 
recurrence [28]. In contrast, a prospective study 
found similar BNP levels in patients with AF and 
SR, suggesting that the peptide was not associated 
with AF [29]. Thus, the relationship between BNP 
level, and the chronicity or burden of AF, remains 
controversial. In our study, NT-proBNP levels were 
elevated in patients with HCM, but were not asso-
ciated with either PWD or atrial dyssynchrony. The 
stimulus for BNP release is myocyte stretching 
rather than the transmural pressure load [30]. For 
this reason, NT-proBNP seems to be a poor marker 
of atrial electrical remodeling induced by chronic 
pressure loading. 
Limitations of the study
Our study had a few limitations. We did not 
perform follow-up. Our results should be validated 
in a follow-up study identifying the relationships 
of AF predictors not only to each other but also to 
clinical endpoints including AF. Phasic volumetric 
assessment of LA could be performed using 3-di-
mensional echocardiography.
Conclusions
PWD and inter-atrial dysynchrony seem to 
independently promote AF, although both are 
associated with LA reservoir function in HCM po-
pulations. The NT-proBNP level is not associated 
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with these 2 AF predictors in patients with HCM. 
Analysis of all 3 markers in terms of predicting 
AF development might yield useful information 
on HCM patients with a propensity toward de-
velopment of AF. Further studies of the power of 
using all 3 parameters together to predict AF in 
HCM populations are needed.
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